Assessment of Foralumab Safety and Modulation of Microglial Activation in Alzheimer's Disease

Clinical trial NCT06489548 · RECRUITING

Trial details

NCT number: NCT06489548
Sponsor: Brigham and Women's Hospital
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Dementia Alzheimers Disease Mild Cognitive Impairment Due to Alzheimer's Disease

Start date: 2025-09-16
Primary completion: 2026-06-01
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.